Incidence of pediatric melanoma on the decline
the ONA take:
According to a new study published in the Journal of Pediatrics, researchers from Case Western University and University Hospitals in Cleveland, Ohio, have found that the incidence of pediatric melanoma in the United States has declined from 2004-2010 despite other studies indicating that the incidence has been increasing.
For the study, researchers used data from the Surveillance, Epidemiology and End Results (SEER) databases to identify new cases of melanoma in pediatric patients between 2000 and 2010. Results showed that there were a total of 1,185 new cases of pediatric melanoma during that 10-year period.
The researchers found that the number of new cases decreased by 12% each year from 2004 to 2010. During the 10-year period studied, researchers observed a 7% decrease per year for boys, and from 2003 to 2010, there was an 11% decrease per year for 15 to 19-year-olds.
The authors suggest that effective public health initiatives, a transition to more indoor activities, and improved parental awareness to protect children from sun damage may be factors for the reduction of pediatric melanoma cases.
Incidence of pediatric melanoma in the United States has declined from 2004-2010.
Sign Up for Free e-newsletters
- Is Radioimmunotherapy a Path Forward for Melanoma?
- FDA Approves Mogamulizumab-kpkc for Rare Subtypes of Non-Hodgkin Lymphoma
- New PDL1 Inhibitors for Non-small Cell Lung Cancer: Focus on Pembrolizumab
- Intensive Chemotherapy May Not Be Effective in MDS or AML After MDS
- ASCO Endorses SIO Guideline for Integrative Therapies in Breast Cancer
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- Seeking Reliable Information on Herbal Products
- Disparities Remain in Prevalence of Cancer Screening Tests
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- 8 Hours of Bedrest May Be Ideal After Intrathecal Chemotherapy in Hematologic Cancers
- Combined Digital Screening Best for Detecting Breast Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|